FindTrial
Sign In

The study of Linazolam risk signal mining in hospital electronic medical records based on tree-based scan statistics.

The study of Linazolam risk signal mining in hospital electronic medical records based on tree-based scan statistics.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102419
Enrollment
Unknown
Registered
2025-05-14
Start date
2024-12-06
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection

Interventions

Linezolid group vs. Non linezolid group:NA

Sponsors

Shandong Provincial Qianfoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 75, without gender restrictions. 2. Patients with a confirmed diagnosis of infection during their hospital stay. 3. A washout period of 12 months is required before enrollment for the linezolid group.

Exclusion criteria

Exclusion criteria: 1.Patients with incomplete information, such as age, gender, BMI .

Design outcomes

Primary

MeasureTime frame
Adverse reactions;sensitivity;specificity;—

Countries

China

Contacts

Public ContactHuang Xin

Shandong Provincial Qianfoshan Hospital

13791120711@126.com+86 531 89268349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026